ImmunologybioRxiv
Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy
V. Joers, B. C. Murray, C. McLaughlin…·M. G. Tansey
This study shows that targeting CB2 with SMM-189 reduces alpha-synuclein aggregates and neuroinflammation in a rat model of Parkinson's disease.
DOI 10.1186/s12974-024-03221-5